StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
QTTBQ32 Bio Inc.
stockpulse.co.kr
Nasdaq
$8.48▼ 1.97%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $175.2MShares out 20.7M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

20
  • 8.27After-hours26.08.28 05:10
    4Ownership#●●●

    Q32 Bio Inc.

    Insider Jodie Morrison of Q32 Bio Inc. reported a change in beneficial ownership of securities effective August 25, 2026. This filing, submitted via SEC Form 4, officially discloses the transaction details regarding the insider's equity holdings.…more

    $8.48-1.97%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 8.27After-hours26.08.28 05:10
    4Ownership

    Q32 Bio Inc.

    Insider Kalowski Lee of Q32 Bio Inc. reported a change in beneficial ownership of securities effective August 25, 2026. This filing serves as the official SEC disclosure of the insider's equity transaction via Form 4.…more

    $8.48-1.97%vs prev close
    View filingShare
  • 8.27After-hours26.08.28 05:10
    4Ownership

    Q32 Bio Inc.

    Insider Violette Shelia M. of Q32 Bio Inc. filed a Form 4 on August 25, 2026, reporting changes in beneficial ownership of securities. This filing serves as an official disclosure of the insider's equity transactions to the SEC.…more

    $8.48-1.97%vs prev close
    View filingShare

19 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.30Pre-market26.09.30 22:19
    #●●●#●●●#●●●

    Q32 Bio Reports Positive Phase 2a Results for Alopecia Treatment Bempikibart…more

    Q32 Bio announced that its alopecia areata treatment, Bempikibart, demonstrated clinically meaningful efficacy and durable responses in a Phase 2a clinical trial. The company plans to advance the drug into registration-directed studies in the first half of 2027 based on these results.…more

    $8.48-1.97%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.21Pre-market26.09.21 22:23

    ●●●●●●●● ●●●●● ●●●●●●

    Q32 Bio will present 36-week results and initial post-treatment data from its Phase 2a SIGNAL-AA trial at the EADV Congress. The study evaluates the efficacy of bempikibart in patients with severe alopecia areata.…more

    $8.48-1.97%vs prev close
    ShareBenzinga

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →